News
Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...
Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...
Pulmonary Drug Delivery System Market Size to Worth USD 73.14 Billion by 2031 | The Insight Partners
According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...
First of its kind inhaler for conditions beyond asthma and COPD to reshape respiratory drug delivery
Cambridge-based start-up rolls out industry-first inhaler for delivering large amounts of drug in a single inhalation, enabling next-gen inhaled biologics for novel therapiesCAMBRIDGE, 24 June 2025: ...
Breathing should be effortless . But for millions, conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease) ...
Yoga can be a valuable complement to pulmonary therapy for chronic respiratory diseases, such as COPD and asthma. By ...
1d
Verywell Health on MSNHow Chronic Obstructive Pulmonary Disease (COPD) Is Treated - MSNChronic obstructive pulmonary disease (COPD) can be treated with lifestyle changes, prescription medications, and specialist ...
In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.
A smart sensor developed by Adherium has been cleared by the FDA for use with AstraZeneca's asthma inhaler Airsupra and Breztri for COPD. Skip to main content Friday 27 June 2025 ...
Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.
Bronchiectasis is a chronic lung disease in which the airways (bronchi) become widened and scarred due to repeated inflammation and infection. This damage makes it difficult to clear mucus from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results